205 related articles for article (PubMed ID: 17032757)
1. Hot-spot mimicry of a cytokine receptor by a small molecule.
Thanos CD; DeLano WL; Wells JA
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15422-7. PubMed ID: 17032757
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of immunosuppression by the therapeutic antibody daclizumab.
Yang H; Wang J; Du J; Zhong C; Zhang D; Guo H; Guo Y; Ding J
Cell Res; 2010 Dec; 20(12):1361-71. PubMed ID: 20820193
[TBL] [Abstract][Full Text] [Related]
3. The structure of interleukin-2 complexed with its alpha receptor.
Rickert M; Wang X; Boulanger MJ; Goriatcheva N; Garcia KC
Science; 2005 Jun; 308(5727):1477-80. PubMed ID: 15933202
[TBL] [Abstract][Full Text] [Related]
4. NMR characterization of interleukin-2 in complexes with the IL-2Ralpha receptor component, and with low molecular weight compounds that inhibit the IL-2/IL-Ralpha interaction.
Emerson SD; Palermo R; Liu CM; Tilley JW; Chen L; Danho W; Madison VS; Greeley DN; Ju G; Fry DC
Protein Sci; 2003 Apr; 12(4):811-22. PubMed ID: 12649439
[TBL] [Abstract][Full Text] [Related]
5. The structure of the interleukin-15 alpha receptor and its implications for ligand binding.
Lorenzen I; Dingley AJ; Jacques Y; Grötzinger J
J Biol Chem; 2006 Mar; 281(10):6642-7. PubMed ID: 16377614
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15.
Ring AM; Lin JX; Feng D; Mitra S; Rickert M; Bowman GR; Pande VS; Li P; Moraga I; Spolski R; Ozkan E; Leonard WJ; Garcia KC
Nat Immunol; 2012 Dec; 13(12):1187-95. PubMed ID: 23104097
[TBL] [Abstract][Full Text] [Related]
7. Human IL-2Rɑ subunit binding modulation of IL-2 through a decline in electrostatic interactions: A computational and experimental approach.
Beig Parikhani A; Bagherzadeh K; Dehghan R; Biglari A; Shokrgozar MA; Riazi Rad F; Zeinali S; Talebkhan Y; Ajdary S; Ahangari Cohan R; Behdani M
PLoS One; 2022; 17(2):e0264353. PubMed ID: 35213635
[TBL] [Abstract][Full Text] [Related]
8. A Computational Investigation of Small-Molecule Engagement of Hot Spots at Protein-Protein Interaction Interfaces.
Xu D; Si Y; Meroueh SO
J Chem Inf Model; 2017 Sep; 57(9):2250-2272. PubMed ID: 28766941
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 2 (IL-2) variants engineered for increased IL-2 receptor alpha-subunit affinity exhibit increased potency arising from a cell surface ligand reservoir effect.
Rao BM; Driver I; Lauffenburger DA; Wittrup KD
Mol Pharmacol; 2004 Oct; 66(4):864-9. PubMed ID: 15385640
[TBL] [Abstract][Full Text] [Related]
10. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors.
Wang X; Rickert M; Garcia KC
Science; 2005 Nov; 310(5751):1159-63. PubMed ID: 16293754
[TBL] [Abstract][Full Text] [Related]
11. How does a small molecule bind at a cryptic binding site?
Shan Y; Mysore VP; Leffler AE; Kim ET; Sagawa S; Shaw DE
PLoS Comput Biol; 2022 Mar; 18(3):e1009817. PubMed ID: 35239648
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule inhibitors of IL-2/IL-2R: lessons learned and applied.
Wilson CG; Arkin MR
Curr Top Microbiol Immunol; 2011; 348():25-59. PubMed ID: 20703966
[TBL] [Abstract][Full Text] [Related]
13. Potent small-molecule binding to a dynamic hot spot on IL-2.
Thanos CD; Randal M; Wells JA
J Am Chem Soc; 2003 Dec; 125(50):15280-1. PubMed ID: 14664558
[TBL] [Abstract][Full Text] [Related]
14. De novo design of potent and selective mimics of IL-2 and IL-15.
Silva DA; Yu S; Ulge UY; Spangler JB; Jude KM; Labão-Almeida C; Ali LR; Quijano-Rubio A; Ruterbusch M; Leung I; Biary T; Crowley SJ; Marcos E; Walkey CD; Weitzner BD; Pardo-Avila F; Castellanos J; Carter L; Stewart L; Riddell SR; Pepper M; Bernardes GJL; Dougan M; Garcia KC; Baker D
Nature; 2019 Jan; 565(7738):186-191. PubMed ID: 30626941
[TBL] [Abstract][Full Text] [Related]
15. Binding of small molecules to an adaptive protein-protein interface.
Arkin MR; Randal M; DeLano WL; Hyde J; Luong TN; Oslob JD; Raphael DR; Taylor L; Wang J; McDowell RS; Wells JA; Braisted AC
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1603-8. PubMed ID: 12582206
[TBL] [Abstract][Full Text] [Related]
16. IL-2Rα mediates temporal regulation of IL-2 signaling and enhances immunotherapy.
Su EW; Moore CJ; Suriano S; Johnson CB; Songalia N; Patterson A; Neitzke DJ; Andrijauskaite K; Garrett-Mayer E; Mehrotra S; Paulos CM; Doedens AL; Goldrath AW; Li Z; Cole DJ; Rubinstein MP
Sci Transl Med; 2015 Oct; 7(311):311ra170. PubMed ID: 26511507
[TBL] [Abstract][Full Text] [Related]
17. The metalloprotease ADAM10 generates soluble interleukin-2 receptor alpha (sCD25) in vivo.
Kirschke S; Ogunsulire I; Selvakumar B; Schumacher N; Sezin T; Rose-John S; Scheffold A; Garbers C; Lokau J
J Biol Chem; 2022 Jun; 298(6):101910. PubMed ID: 35398356
[TBL] [Abstract][Full Text] [Related]
18. The soluble IL-2 receptor α/CD25 as a modulator of IL-2 function.
Lokau J; Petasch LM; Garbers C
Immunology; 2024 Mar; 171(3):377-387. PubMed ID: 38037265
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the role of the interleukin-2 receptor gamma chain in ligand binding.
Liparoto SF; Myszka DG; Wu Z; Goldstein B; Laue TM; Ciardelli TL
Biochemistry; 2002 Feb; 41(8):2543-51. PubMed ID: 11851401
[TBL] [Abstract][Full Text] [Related]
20. [IL-2-receptor associated action of the modified peptide fragments of human IL-2 on macrophages].
Onoprienko LV; Mikhaleva II; Voĭtenkov BO; Ivanov VT
Bioorg Khim; 2012; 38(4):413-20. PubMed ID: 23189555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
